Your browser doesn't support javascript.
loading
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.
Kasikara, Canan; Davra, Viralkumar; Calianese, David; Geng, Ke; Spires, Thomas E; Quigley, Michael; Wichroski, Michael; Sriram, Ganapathy; Suarez-Lopez, Lucia; Yaffe, Michael B; Kotenko, Sergei V; De Lorenzo, Mariana S; Birge, Raymond B.
Afiliação
  • Kasikara C; Rutgers University, Biomedical and Health Sciences Center, Department of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Davra V; Rutgers University, Biomedical and Health Sciences Center, Department of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Calianese D; Rutgers University, Biomedical and Health Sciences Center, Department of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Geng K; Rutgers University, Biomedical and Health Sciences Center, Department of Microbiology, Biochemistry and Molecular Genetics, Cancer Center, Rutgers- New Jersey Medical School, Newark, New Jersey.
  • Spires TE; Bristol-Myers Squibb, Princeton, New Jersey.
  • Quigley M; Bristol-Myers Squibb, Princeton, New Jersey.
  • Wichroski M; Bristol-Myers Squibb, Princeton, New Jersey.
  • Sriram G; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Suarez-Lopez L; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Yaffe MB; Center for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Kotenko SV; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • De Lorenzo MS; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
  • Birge RB; Center for Precision Cancer Medicine, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Cancer Res ; 79(10): 2669-2683, 2019 05 15.
Article em En | MEDLINE | ID: mdl-30877108
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Proteínas Tirosina Quinases / Receptor de Morte Celular Programada 1 / Neoplasias de Mama Triplo Negativas / Aminopiridinas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Proteínas Tirosina Quinases / Receptor de Morte Celular Programada 1 / Neoplasias de Mama Triplo Negativas / Aminopiridinas / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article